Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder, a bone- and canal-sparing implant for total shoulder arthroplasty. Limited launch is underway, with expanded release slated for 2H18.
The device is accompanied by a single instrument tray to support O.R. efficiency, and features a 3D porous structure and bone cage to enhance biologic fixation.
The Equinoxe line, first launched in 2004, includes components for primary, revision, reverse, fracture, resurfacing, etc.